Emily C Gathright1, Elena Salmoirago-Blotcher2, Julie DeCosta3, Brittany L Balletto3, Marissa L Donahue3, Melissa M Feulner3, Dean G Cruess4, Rena R Wing5, Michael P Carey6, Lori A J Scott-Sheldon6. 1. Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Providence, RI, USA; Department of Psychiatry and Human Behavior, Alpert School of Medicine, Brown University, Providence, RI, USA. Electronic address: emily_gaithright@brown.edu. 2. Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Providence, RI, USA; Department of Medicine, Alpert School of Medicine, Brown University, Providence, RI, USA; Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA. 3. Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Providence, RI, USA. 4. Department of Psychological Sciences, University of Connecticut, Storrs, CT, USA. 5. Department of Psychiatry and Human Behavior, Alpert School of Medicine, Brown University, Providence, RI, USA; Weight Control and Diabetes Research Center, The Miriam Hospital, Providence, RI, USA. 6. Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Providence, RI, USA; Department of Psychiatry and Human Behavior, Alpert School of Medicine, Brown University, Providence, RI, USA; Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, USA.
Abstract
BACKGROUND: Transcendental Meditation (TM) as a stress management technique may offer an adjunctive strategy to improve health and well-being in adults with cardiovascular disease (CVD). OBJECTIVES: To examine the efficacy of TM to improve aspects of cardiovascular health and psychological functioning in adults with CVD. METHOD: Studies (a) evaluating TM in adults with hypertension or CVD and (b) assessing a physiological or psychological outcome were retrieved and meta-analyzed. Weighted mean effect sizes were computed to assess between- and within-group changes. RESULTS: Nine studies met inclusion criteria (N = 851; mean age = 60 ± 8 years; 47% women). Between-group analyses revealed no differences between TM and control groups. However, within-group (i.e., pre- to post-intervention) analyses revealed reductions in systolic (d+ = 0.31) and diastolic (d+ = 0.53) blood pressure (BP) for the TM group. There were no changes in depressive symptoms for TM or control participants. CONCLUSIONS: TM was associated with within-group (but not between-groups) improvements in BP. Continued research using randomized controlled trials with larger samples, and measuring psychophysiological outcomes at longer follow-up intervals is recommended.
BACKGROUND: Transcendental Meditation (TM) as a stress management technique may offer an adjunctive strategy to improve health and well-being in adults with cardiovascular disease (CVD). OBJECTIVES: To examine the efficacy of TM to improve aspects of cardiovascular health and psychological functioning in adults with CVD. METHOD: Studies (a) evaluating TM in adults with hypertension or CVD and (b) assessing a physiological or psychological outcome were retrieved and meta-analyzed. Weighted mean effect sizes were computed to assess between- and within-group changes. RESULTS: Nine studies met inclusion criteria (N = 851; mean age = 60 ± 8 years; 47% women). Between-group analyses revealed no differences between TM and control groups. However, within-group (i.e., pre- to post-intervention) analyses revealed reductions in systolic (d+ = 0.31) and diastolic (d+ = 0.53) blood pressure (BP) for the TM group. There were no changes in depressive symptoms for TM or control participants. CONCLUSIONS: TM was associated with within-group (but not between-groups) improvements in BP. Continued research using randomized controlled trials with larger samples, and measuring psychophysiological outcomes at longer follow-up intervals is recommended.
Authors: Ahmed Tawakol; Amorina Ishai; Richard Ap Takx; Amparo L Figueroa; Abdelrahman Ali; Yannick Kaiser; Quynh A Truong; Chloe Je Solomon; Claudia Calcagno; Venkatesh Mani; Cheuk Y Tang; Willem Jm Mulder; James W Murrough; Udo Hoffmann; Matthias Nahrendorf; Lisa M Shin; Zahi A Fayad; Roger K Pitman Journal: Lancet Date: 2017-01-12 Impact factor: 79.321
Authors: Maura Paul-Labrador; Donna Polk; James H Dwyer; Ivan Velasquez; Sanford Nidich; Maxwell Rainforth; Robert Schneider; C Noel Bairey Merz Journal: Arch Intern Med Date: 2006-06-12
Authors: Robert D Brook; Lawrence J Appel; Melvyn Rubenfire; Gbenga Ogedegbe; John D Bisognano; William J Elliott; Flavio D Fuchs; Joel W Hughes; Daniel T Lackland; Beth A Staffileno; Raymond R Townsend; Sanjay Rajagopalan Journal: Hypertension Date: 2013-04-22 Impact factor: 10.190
Authors: Robert H Schneider; Clarence E Grim; Maxwell V Rainforth; Theodore Kotchen; Sanford I Nidich; Carolyn Gaylord-King; John W Salerno; Jane Morley Kotchen; Charles N Alexander Journal: Circ Cardiovasc Qual Outcomes Date: 2012-11-13
Authors: Robert H Schneider; Charles N Alexander; Frank Staggers; Maxwell Rainforth; John W Salerno; Arthur Hartz; Stephen Arndt; Vernon A Barnes; Sanford I Nidich Journal: Am J Cardiol Date: 2005-05-01 Impact factor: 2.778
Authors: C N Alexander; R H Schneider; F Staggers; W Sheppard; B M Clayborne; M Rainforth; J Salerno; K Kondwani; S Smith; K G Walton; B Egan Journal: Hypertension Date: 1996-08 Impact factor: 10.190
Authors: Pedro L Valenzuela; Pedro Carrera-Bastos; Beatriz G Gálvez; Gema Ruiz-Hurtado; José M Ordovas; Luis M Ruilope; Alejandro Lucia Journal: Nat Rev Cardiol Date: 2020-10-09 Impact factor: 32.419
Authors: Yolanda Álvarez-Pérez; Amado Rivero-Santana; Lilisbeth Perestelo-Pérez; Andrea Duarte-Díaz; Vanesa Ramos-García; Ana Toledo-Chávarri; Alezandra Torres-Castaño; Beatriz León-Salas; Diego Infante-Ventura; Nerea González-Hernández; Leticia Rodríguez-Rodríguez; Pedro Serrano-Aguilar Journal: Int J Environ Res Public Health Date: 2022-03-13 Impact factor: 3.390